Providence Capital Advisors, LLC Johnson & Johnson Transaction History
Providence Capital Advisors, LLC
- $462 Million
- Q1 2025
A detailed history of Providence Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 2,940 shares of JNJ stock, worth $444,880. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,940
Previous 2,939
0.03%
Holding current value
$444,880
Previous $425,000
14.59%
% of portfolio
0.11%
Previous 0.09%
Shares
29 transactions
Others Institutions Holding JNJ
# of Institutions
4,659Shares Held
1.73BCall Options Held
25MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA234MShares$35.4 Billion0.72% of portfolio
-
Black Rock Inc. New York, NY198MShares$30 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$20.2 Billion0.94% of portfolio
-
Geode Capital Management, LLC Boston, MA59.4MShares$8.99 Billion0.79% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$8.18 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $396B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...